Guyer Charles Greg 4

What Happened Greg Guyer, EVP and Chief Technical Officer of BioMarin Pharmaceuticals (BMRN), disposed of 1,693 shares on March 17, 2026 to satisfy tax withholding related to an equity event. The shares were valued at $56.05 each, totaling approximately $94,893. This transaction is a tax withholding (code F), not an open-market sale or a new purchase.

Key Details

• Transaction date: 2026-03-17
• Transaction type/code: Payment of exercise price or tax liability (Code F) — shares were surrendered/withheld to cover taxes
• Shares disposed: 1,693
• Price per share: $56.05
• Approximate value: $94,893
• Filing date: 2026-03-19 (filed within two business days of the transaction; appears timely)
• Shares owned after transaction: Not specified in the Form 4 filing
• Other notes: No 10b5-1 plan or late filing flag indicated in the provided filing

Context This was a tax-withholding disposition (often done to cover withholding obligations after option exercises or vesting). Such withholdings reduce an insider’s reported share count but are routine and do not necessarily indicate a change in the insider’s view of the company. Purchases generally provide clearer signals of insider confidence than routine tax-related disposals.